Therapy of idiopathic acquired alveolar proteinosis with granulocyte-macrophage colony-stimulating factor (GM-CSF).

被引：0
|
作者：
Seymour, JF
Presneill, JJ
Doyle, IR
Vincent, JM
Pain, MC
Downie, GH
Schoch, OD
Moore, PE
Dunn, AR
机构：
[1] Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[4] Buffalo Med Grp, Buffalo, NY USA
[5] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[6] Childrens Hosp, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A705 / A705
页数：1
相关论文
共 50 条
  • [1] Antibody Against Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Inhaled GM-CSF for Pulmonary Alveolar Proteinosis
    Tazawa, R.
    Ueda, T.
    Abe, M.
    Tatsumi, K.
    Eda, R.
    Kondoh, S.
    Morimoto, K.
    Tanaka, T.
    Yamaguchi, E.
    Takahashi, A.
    Oda, M.
    Ishii, H.
    Izumi, S.
    Sugiyama, H.
    Nakagawa, A.
    Tomii, K.
    Suzuki, M.
    Konno, S.
    Ohkouchi, S.
    Tode, N.
    Handa, T.
    Hirai, T.
    Inoue, Y.
    Arai, T.
    Asakawa, K.
    Sakagami, T.
    Hashimoto, A.
    Tanaka, T.
    Takada, T.
    Mikami, A.
    Kitamura, N.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis
    Seymour, JF
    Dunn, AR
    Vincent, JM
    Presneill, JJ
    Pain, MC
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (25): : 1924 - 1925
  • [3] Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis
    Seymour, JF
    Presneill, JJ
    Schoch, OD
    Downie, GH
    Moore, PE
    Doyle, IR
    Vincent, JM
    Nakata, K
    Kitamura, T
    Langton, D
    Pain, MC
    Dunn, AR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (02) : 524 - 531
  • [4] FUTURE USES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)
    JONES, TC
    STEM CELLS, 1994, 12 : 229 - 240
  • [5] CUTANEOUS REACTION TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)
    SCOTT, G
    JOURNAL OF CUTANEOUS PATHOLOGY, 1993, 20 (05) : 474 - 476
  • [6] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF), HYPOCALCEMIA, AND HYPOMAGNESEMIA
    POTTER, MN
    MOTT, MG
    OAKHILL, A
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) : 715 - 715
  • [7] Granulocyte macrophage-colony stimulating factor (GM-CSF) and alveolar proteinosis.
    Kleykamp, BO
    Garcia, H
    Romberg, D
    Baughman, RP
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A705 - A705
  • [8] Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF
    Wadhwa, M
    Skog, ALH
    Bird, C
    Ragnhammar, P
    Lilljefors, M
    Gaines-Das, R
    Mellstedt, H
    Thorpe, R
    CLINICAL CANCER RESEARCH, 1999, 5 (06) : 1353 - 1361
  • [9] IS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) SAFE IN MYELODYSPLASTIC SYNDROMES
    MITTELMAN, M
    FLORU, S
    PICK, AI
    HAEMATOLOGIA, 1994, 26 (02) : 111 - 115
  • [10] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
    LOWENBERG, B
    DEGREEF, GE
    WIELENGA, JJ
    ANTI-CANCER DRUGS, 1993, 4 : 17 - 20
12345